Mass Torts
Mass Torts Law Blog
Johnson & Johnson Slammed with $29.5M Verdict Over Baby Powder Suit
Posted in Mass Torts
A California state jury found that pharmaceutical and manufacturing giant Johnson & Johnson’s talcum-based baby powder contained cancer-causing asbestos and caused a woman’s mesothelioma diagnosis. The jury awarded the woman a staggering $29.5 million.
Gout Treatment, Uloric, Found to Pose an Increased Risk of Death
Posted in Mass Torts
The FDA has added a black box warning on uloric (febuxostat), finding that the gout treatment poses an increased risk of heart-related death compared to other gout treatment. Febuxostat is an FDA-approved medication for the treatment of gout. Gout is a type of arthritis that occurs when uric acid builds… Continue reading
Pradaxa (Dabigatran) Trials Continue Nationwide
Posted in Mass Torts
In an October 2018, trial in West Virginia, a federal jury found that Boehringer Ingelheim Pharmaceuticals Inc. was not forthright about the risk of potential bleeding injuries with its drug, Pradaxa (Dabigatran). The jury awarded the plaintiff $250,000 for medical expenses and pain and suffering, as well as $1 million in… Continue reading
Bard Hernia Mesh Litigation Update
Posted in Mass Torts
Thousands of individuals have filed Bard mesh lawsuits against Bard and its corporate subsidiary, Davol. The Bard Hernia Mesh litigation, is currently pending in Rhode Island state court, as well as in federal court, in the Southern District of Ohio. The Rhode Island state court litigation began in late 2017,… Continue reading
Drugmakers React to Reinstatement of Incretin Mimetics Cases
Posted in Mass Torts
As we have previously reported, safety concerns regarding incretin mimetics (such as Byetta, Januvia/Janumet and Victoza), led to more than a thousand lawsuits being filed across the country. Reports suggest that people taking the medications for the treatment of Type 2 diabetes may be at an increased risk of developing… Continue reading
The New Jersey Supreme Court’s Latest Decision Affecting Pharmaceutical Multicounty Litigation
Posted in Mass Torts
On October 3, 2018, the New Jersey Supreme Court made its long-awaited decision in the Accutane Multicounty Litigation. Developed by the New Jersey-based pharmaceutical giant Hoffman-La Roche, Accutane is a prescription acne treatment that has been found to be linked to inflammatory bowel disease. Numerous plaintiffs filed lawsuits in New… Continue reading
FDA Bans Zhejiang Huahai Pharmaceutical Import as Valsartan Recall Continues
Posted in Mass Torts
The U.S. Food and Drug Administration (FDA) has banned all imports of drugs and drug products from Zhejiang Huahai Pharmaceutical, which manufactured valsartan, a high blood pressure medication that had a possible carcinogenic impurity. In July 2018, the FDA and European Medicines Agency (EMA) supported a voluntary recall of lots… Continue reading
Valsartan Class Action Filed
Posted in Mass Torts
A recent class action was filed in New York against the companies responsible for distributing or selling drugs containing tainted valsartan. The lawsuit, brought by a woman and her husband, alleges negligence, fraud, and manufacturing a defective product, among other claims. It is expected that personal injury claims may soon follow.
Global Settlement Order Entered as Abilify Litigation Moves Forward
Posted in Mass Torts
In May 2018, Judge M. Casey Rogers, who is overseeing the federal Abilify litigation, entered an Order to establish the “initial parameters by which the global mediation of this matter will proceed.” The parties were given 120 days (from May 1, 2018 until September 1, 2018) to finalize the framework… Continue reading
Gilead Facing Multiple Claims of Purposefully Delaying Safer HIV Drug Alternatives
Posted in Mass Torts
It has been alleged that Gilead Sciences, an HIV drugmaker, purposefully delayed the introduction of safer, life-saving medications in order to increase profits. In 2001, Gilead received approval for the sale of HIV drugs containing the compound, tenofovir disoproxil fumarate (TDF). Unfortunately, TDF medications have been linked to severe kidney… Continue reading
